Share on LinkedIn Share on Twitter Share on Facebook DFIN IPO Report - July 2021 Edition Share on LinkedIn Share on Twitter Share on Facebook "Deal makers were working from the beach as the IPO heat wave continued in July with 61 non-SPAC offerings raising ~$16 billion*. SPAC IPOs continued to normalize with 30 SPACs raising ~$5.7 billion*. Public debuts via De-SPACs were robust, with 29 SPACs completing their business combination ringing the bells at the NYSE & Nasdaq exchanges." Craig Clay, President, Donnelley Financial Solutions Congratulations to the 91 issuers who made their public debut in July via an IPO raising $22 billion* including our clients: Black Spade Acquisition Blend Lab Blue Foundry Bancorp Bridge Investment Group Holdings Candel Therapeutics Caribou Biosciences Core & Main Couchbase CS Disco Cytek Biosciences DA32 Life Science Tech Acquisition Dole Erasca F45 Training Gambling.Com Good Works II Acquisition HCW Biologics Icosavax Imago BioSciences Instructure Membership Collective Group MeridianLink Nuvalent Omega Therapeutics PowerSchool Paycor HCM Rallybio Rani Therapeutics RxSight Ryan Specialty Group Sight Sciences Sophia Genetics Stevanato Group Tenaya Therapeutics Traeger TScan Therapeutics VTEX Xponential Fitness Zevia To learn more, download the report below. Report DFIN IPO Report - July 2021 Edition Download